We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$52.9M
2
WST icon
West Pharmaceutical
WST
+$39.7M
3
AMED
Amedisys
AMED
+$36.8M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34M
5
SPOT icon
Spotify
SPOT
+$34M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALK icon
226
Alaska Air
ALK
$5.29B
$16.5M 0.13%
454,100
+63,150
+16% +$2.06M
EVRG icon
227
Evergy
EVRG
$19.1B
$16.3M 0.13%
+275,400
New +$16.3M
AEP icon
228
American Electric Power
AEP
$69.6B
$16.2M 0.12%
203,044
-9,255
-4% -$755K
MRSH
229
Marsh
MRSH
$90.5B
$16.1M 0.12%
150,325
-31,250
-17% -$3.16M
NOV icon
230
NOV
NOV
$6.93B
$16.1M 0.12%
1,311,460
– –
EVH icon
231
Evolent Health
EVH
$348M
$16M 0.12%
2,246,832
-246,116
-10% -$1.65M
PNC icon
232
PNC Financial Services
PNC
$99.7B
$16M 0.12%
151,998
+27,037
+22% +$2.85M
CLX icon
233
Clorox
CLX
$11.6B
$15.9M 0.12%
72,625
-35,175
-33% -$7.03M
LSCC icon
234
Lattice Semiconductor
LSCC
$17.6B
$15.9M 0.12%
559,700
– –
DG icon
235
Dollar General
DG
$28B
$15.9M 0.12%
83,275
-111,875
-57% -$20.2M
MTCH icon
236
Match Group
MTCH
$9.19B
$15.8M 0.12%
147,800
-34,275
-19% -$2.86M
NBIX icon
237
Neurocrine Biosciences
NBIX
$16.8B
$15.8M 0.12%
+129,600
New +$14.3M
DRI icon
238
Darden Restaurants
DRI
$23.3B
$15.8M 0.12%
208,650
-217,158
-51% -$15.4M
RARE icon
239
Ultragenyx Pharmaceutical
RARE
$2.45B
$15.8M 0.12%
+202,025
New +$13.4M
CB icon
240
Chubb
CB
$135B
$15.8M 0.12%
124,636
+24,858
+25% +$2.88M
HXL icon
241
Hexcel
HXL
$7.79B
$15.6M 0.12%
345,513
-1,281,701
-79% -$45.6M
POR icon
242
Portland General Electric
POR
$5.8B
$15.5M 0.12%
371,508
-74,225
-17% -$3.4M
EW icon
243
Edwards Lifesciences
EW
$49.6B
$15.3M 0.12%
222,075
– –
AGNC icon
244
AGNC Investment
AGNC
$12.4B
$15.3M 0.12%
1,185,725
-1,173,775
-50% -$14.7M
PTCT icon
245
PTC Therapeutics
PTCT
$5.68B
$15M 0.12%
+296,107
New +$14.5M
CSGP icon
246
CoStar Group
CSGP
$11.7B
$15M 0.12%
211,000
-49,250
-19% -$3.18M
PAYX icon
247
Paychex
PAYX
$41.6B
$15M 0.12%
197,775
+109,750
+125% +$7.61M
NEE icon
248
NextEra Energy
NEE
$181B
$14.9M 0.11%
248,236
-11,308
-4% -$677K
V icon
249
Visa
V
$684B
$14.8M 0.11%
76,600
-14,100
-16% -$2.58M
NVRO
250
DELISTED
NEVRO CORP.
NVRO
$14.8M 0.11%
+123,717
New +$14.7M
8 9
10
11 12

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.